Search company, investor...

Stage

Series F | Alive

Total Raised

$143.72M

Last Raised

$121.72M | 3 yrs ago

About PegBio

PegBio is a bio-pharmaceutical company engaging in manufacturing polyethylene glycol (PEG) and development of PEGylation technology leading to PEGylated drugs as putative new molecule entities (pNMEs) in China.

Headquarters Location

218 Xinghu Street SIP

Suzhou, Jiangsu,

China

0512-62956128

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

PegBio Patents

PegBio has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/28/2016

1/19/2021

Diabetes, G protein coupled receptors, Peptide hormones, Hepatology, Nutrition

Grant

Application Date

12/28/2016

Grant Date

1/19/2021

Title

Related Topics

Diabetes, G protein coupled receptors, Peptide hormones, Hepatology, Nutrition

Status

Grant

Latest PegBio News

09:00 EDT China's PegBio Selects LifeSphere by ArisGlobal for Safety Case Processing

Oct 27, 2022

News provided by Share this article LifeSphere Safety increases its customer footprint, further solidifying its safety market leadership position. MIAMI, Oct. 27, 2022 /PRNewswire/ -- ArisGlobal , the leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere®, has expanded the global adoption of LifeSphere Safety by adding PegBio Co., Ltd.  to its customer roster. PegBio selected LifeSphere MultiVigilance, a flagship product within the market-leading safety product line, to transition its pharmacovigilance from Contract Research Organization (CRO) services to in-house practices with the leading pharmacovigilance software. ArisGlobal Logo (PRNewsfoto/ArisGlobal) "At PegBio, we are laser-focused on fighting chronic disease with safe, novel, and effective therapies, and we hold patient safety in the highest regard," shares Ruifang Liang, Senior VP of PegBio. "We believe that by moving our pharmacovigilance strategy to ArisGlobal's LifeSphere, we will be able to not only meet, but exceed, safety expectations and efficiencies." LifeSphere Safety will enable PegBio, a biopharma specialized in the development of diabetes and obesity therapies, to bring operations in-house and control drug development through customized service, authority connection, cloud service, and bilingual language translation capabilities. "LifeSphere Safety is several years ahead of any other safety solution on the market, and we are thrilled to welcome PegBio to our customer roster as an innovative organization working towards chronic disease therapies," says Ye Zha, Head of Country, China, at ArisGlobal. "With the increased prioritization of safety, in-house pharmacovigilance has become essential. LifeSphere MultiVigilance will provide a critical level of support and enhance PegBio's ability to safely and efficiently develop and deliver drugs in this key global market and beyond." By adding PegBio to its portfolio, ArisGlobal continues growing its commitment to pharmacovigilance and the safety of global drug development along with its ever-expanding footprint within China's life sciences sector. For more information about ArisGlobal and the LifeSphere Safety platform, please visit arisglobal.com . About PegBio Founded in 2008, Pegbio Co., Ltd. is a biomedical enterprise committed to the research and development and production of innovative drugs in the field of chronic disease treatment, which has developed a series of advantageous products, including polypeptide drugs, protein drugs, and small molecule drugs through independent research and development. About LifeSphere LifeSphere® is the trusted partner for global pharmaceutical and biotechnology companies, health authorities, and contract research organizations. Helping accelerate product development, organize clinical trials, manage compliance, and streamline collaboration across teams, LifeSphere empowers safer, faster life science breakthroughs. As the flagship platform of ArisGlobal, LifeSphere is a market-leading solution built on 40 years of industry partnership and continues to evolve in collaboration with hundreds of trusted customers worldwide. For more information visit lifesphere.arisglobal.com. About ArisGlobal ArisGlobal is led by passionate individuals who support life sciences leaders in developing and monitoring breakthrough medicines and therapies. With more than 35 years of expertise in the life sciences industry, ArisGlobal develops technology products within the platform LifeSphere to power pharmaceutical and biotech research and development. Building on our commitment to corporate social responsibility and sustainability initiatives, we give back to the communities where we live and work – in the U.S, Europe, India, Japan, and China. For more information visit https://www.arisglobal.com/ . SOURCE ArisGlobal

PegBio Frequently Asked Questions (FAQ)

  • Where is PegBio's headquarters?

    PegBio's headquarters is located at 218 Xinghu Street, Suzhou.

  • What is PegBio's latest funding round?

    PegBio's latest funding round is Series F.

  • How much did PegBio raise?

    PegBio raised a total of $143.72M.

  • Who are the investors of PegBio?

    Investors of PegBio include bioVENTURE, Yuanfeng Capital, Qianhai Fund of Funds, Yunfeng Capital, TF Capital and 11 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.